Investigating Claims – Sancilio Pharmaceuticals Company
Are you concerned about your investment in Sancilio Pharmaceuticals Company? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
Sancilio Pharmaceuticals Company, Inc. is an integrated specialty pharmaceutical company. The company develops, manufactures, and commercializes pharmaceutical products, over-the-counter and behind-the-counter products, and dietary supplements in the dental and women’s health markets, according to Bloomberg.
The company along with two subsidiaries and affiliates, has filed a petition for relief under Chapter 11 in the Bankruptcy Court for the District of Delaware on June 5, 2018.
According to SEC filings, Sancilio Pharmaceuticals Company filed a Form D to raise capital from investors in Riviera Beach, FL. The total offering amount was $5,500,000.
Investments such as these are typically sold by brokerage firms in exchange for a large up front commission. High fees can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%.
The problem with private placement investments such as Sancilio Pharmaceuticals Company is that they typically involve a high degree of risk. They are also often sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks or bonds.
Securities Investigation
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for unsuitably recommending high-risk private placements, like Sancilio Pharmaceuticals Company to investors.
Despite the risks of investing in private placements, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
If you have concerns regarding your investment in Sancilio Pharmaceuticals Company and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visithttps://whitesecuritieslaw.com.
Tags: Sancilio Pharmaceuticals Company, Sancilio Pharmaceuticals Company complaints, Sancilio Pharmaceuticals Company default, Sancilio Pharmaceuticals Company help, Sancilio Pharmaceuticals Company high commissions, Sancilio Pharmaceuticals Company information, Sancilio Pharmaceuticals Company investigation, Sancilio Pharmaceuticals Company investment, Sancilio Pharmaceuticals Company investment losses, Sancilio Pharmaceuticals Company investor relations, Sancilio Pharmaceuticals Company investors, Sancilio Pharmaceuticals Company losses, Sancilio Pharmaceuticals Company ppm, Sancilio Pharmaceuticals Company private placement, Sancilio Pharmaceuticals Company prospectus, Sancilio Pharmaceuticals Company recovery options, Sancilio Pharmaceuticals Company risk, Sancilio Pharmaceuticals Company stock information, Sancilio Pharmaceuticals Company update Last modified: June 6, 2018